EMA — authorised 22 September 2018
- Marketing authorisation holder: TAKEDA PHARMA A/S
- Status: approved
🇪🇺 Alunbrig in European Union
EMA authorised Alunbrig on 22 September 2018
Marketing authorisation
Alunbrig in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Alunbrig approved in European Union?
Yes. EMA authorised it on 22 September 2018.
Who is the marketing authorisation holder for Alunbrig in European Union?
TAKEDA PHARMA A/S holds the EU marketing authorisation.